Skip to main content
Log in

Referat Therapie des Ovarialkarzinoms

  • Hauptprogramm
  • Wissenschaftlicher Teil Krebstherapie
  • Published:
Archives of gynecology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  • Bruckner HW, Cohen CJ, Wallach RC, Kabakow B, Deppe G, Greenspan EM, Gusberg SB, Holland JF (1978) Treatment of advanced ovarian cancer with cis-dichloradiamine-platinum (II/: poor-risk patients with intensive prior therapy). Cancer Treatm Rep 62:555–558

    CAS  Google Scholar 

  • Bush RS, Dembo AJ (1980) Current status of treatment for patients with ovarian cancer. In: Newman CE (ed) Ovarian cancer. Adv Biosc 26:115–135

  • Delclos L, Flechter GH, Rutledge F, Smith JP (1979) The role of radiation therapy in the treatment of epithelial tumors in the ovary. Referat: 12. Int. Cancer Congress. In: Thatcher, vol. VIII. Gyn. Cancer. Pergamon Press, pp 313–319

  • Edmonson JH, Fleming TR, Decker DG, Malkasian GD, Jorgensen EO, Jefferies JA, Web MJ, Kvols LK (1979) Different chemotherapeutic sensitivities and host factors affectin prognosis in advanced ovarian carcinoma versus minimal residual disease. Cancer Treat Rep 63:241–247

    CAS  PubMed  Google Scholar 

  • Ehrlich CE, Einhorn L, Williams SD, Morgan J (1979) Chemotherapy for stage III–IV epithelial ovarian cancer with cis-dichloradiammineplatinum II, Adriamycin, and cyclophosphamide: A preliminary report. Cancer Treat Rep 63:281–288

    CAS  PubMed  Google Scholar 

  • Fournier v DG, Kubli I, Bauer M, Knippenberger H (1979) Comparison of treatment results with radiogold, cobalt-60-tele-therapy and chemotherapy in 330 carcinoma of the ovary. IXth World Congr. of Gynec. and Obstet. Vortr. Nr. 130. Ref. Med. Tribune No. 18. Tokyo

  • Kleine W, Fuchs A, Pfleiderer A (1979) Influence of tamoxifen, danazol, gestagen and oestradiol on endometrial carcinomas and malignant ovarian tumours hetero-transplanted to NU/NU mice in regard to oestrogen and gestagen receptors. First Internat. Congr. on Hormones and Cancer, Rome, Oct. 3–6

  • Kleine W, Teufel G, Pfleiderer A (1979) Xenotransplantation menschlicher Ovarialkarzinome auf nu/nu Mäuse (1979). Vortr. 87. Tagg. Nordwestdtsch. Ges. Gyn., Hamburg

    Google Scholar 

  • Malpas JS (1979) Chemotherapy in the management of ovarian carcinoma: a review. J R Soc Med 72:357–361

    CAS  PubMed  PubMed Central  Google Scholar 

  • Pfleiderer A Jr, Kiyan S (1967) Die Behandlung des Ovarialkarzinoms in der Universitäts-Frauenklinik Tübingen seit 1957 und ihre Ergebnisse. Med Welt 18:3095–3102

    Google Scholar 

  • Pfleiderer A (1979) Medikamentöse Therapie des Ovarialkarzinoms. Therapiewoche 29:441–420

    Google Scholar 

  • Pfleiderer A (1980) Is chemosensitivity-testing worth-while? Report of a cooperative study. FIGO-World Congr. Tokyo. Excerpta Medica

  • Pfleiderer A, Teufel G, Kleine W, Ladner HA, Wrzodek W (1980) Technique and clinical relevance of pretherapeutic testing for ovarian cancer. FIGO-World Congr. Tokyo. Excerpta Medica

  • Rutledge F (1980) Erfahrungen in der Behandlung des Ovarialkarzinoms in USA. Vortr. München 22. 3. 80

  • Sauer H, Wilmanns W (1979) Ovarialkarzinom. In: Internist. Therapie maligner Erkrankungen. In: Bock, Gerok, Hartmann (eds) Klinik der Gegenwart V

  • Schwartz PE, Keating G, Maclusky N, Eisenfeld A (1980) Tamoxifen therapy for advanced ovarian cancer. ASCO-Meeting C443

  • Smith JP, Day TG Jr (1979) Review of ovarian cancer at the university of Texas systems cancer center, M. D. Anderson Hospital and tumor Institute. Am J Obstet Gynecol 135:984–993

    Article  CAS  PubMed  Google Scholar 

  • Teufel G (1979) Proliferation von Karzinomen des weiblichen Genitale und ihre Bedeutung für die zytostatische Therapie. Habilitationsschrift. Freiburg

  • Teufel G, Albrecht A, Bastert G, Drings P, Geier G, Goertler K, Hohorst HJ, Kaufmann M, Klekow M, Kreienberg R, Kubli F, Mattern J, Melchert F, Neunhoeffer J, Pfleiderer A, Schmidt-Matthiesen H, Schuhmann R, Segeth G, Trams G, Vogt-Moykopf I, Volm M, Wayss K, Weber E, Wüst G (1980) Sensibilitätstestung von Ovarialkarzinomen gegen Zytostatika. Ergebnisse der koopoerativen Studiengruppe zur Sensibilitätstestung von Tumoren (KSST). Dtsch. Ges. Gyn. und Geburtshilfe. 43. Tagung, Hamburg 29. 9.–3. 10. 80.

  • Tobias JS, Griffiths CT (1976) Management of ovarian carcinoma. Current concepts and future prospects. N Engl J Med 294:818–823, 877–882

    Article  CAS  PubMed  Google Scholar 

  • Vogl SE, Berenzweig M, Kaplan BH, Moukhtar M, Bulkin W (1979) The CHAD and HAD regimens in advanced ovarian cancer: Combination chemotherapy including cyclophosphamide, hexamethyl melamine, adriamycin, and cisdichlorodiamineplatinum II. Cancer Treat Rep 63:311–317

    CAS  PubMed  Google Scholar 

  • Volm M, Wayss K, Kaufmann M, Mattern J (1979) Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer 15:983–994

    Article  CAS  PubMed  Google Scholar 

  • Williams CJ, Stevenson KE, Buchanan RB, Whithouse JMA (1979) Advanced ovarian carcinoma: A pilot study of cis-dichloradiumineplatinum (II/in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients). Cancer Treat Rep 63:1745–1754

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfleiderer, A. Referat Therapie des Ovarialkarzinoms. Arch. Gynecol. 232, 200–208 (1981). https://doi.org/10.1007/BF02429540

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02429540

Navigation